FDA Approves Drug to Treat Cancer Therapy Complication

by: cancercompass

The U.S. Food and Drug Administration (FDA) approved a cancer drug that fights a serious complication of cancer treatment, reports Reuters.

The drug, Elitek, was recently approved by the FDA for managing levels of plasma uric acid that often build up as a side effect from cancer treatment, according to the drug's manufacturer Sanofi-Aventis. High plasma uric acid levels can lead to tumor lysis syndrome, which is a potentially life-threatening condition.

Elitek was cleared to treat adults with leukemia, lymphoma or solid tumors who are receiving cancer treatments or therapies that are expected to cause tumor lysis syndrome or elevate plasma uric acid levels.